4Devereux RB. Detection of left ventricular hypertrophy by M- mode echocardiography. Anatomic validation, standardization, and comparison to other methods[J]. Hypertension, 1987,9 (2 pt 2) :Ⅱ19-26.
5Maceira AM, Barba J,Varo N, et al. Ultrasonic backscatter and serum marker of cardiac fibrosis in hypertensives [J ]. Hypertension, 2002,39(4) :923-928.
6Mancia G, Facchetti R, Bombelli M, et al. Long-term risk of mortality associated with selective and combined elevation in office, home,and ambulatory blood pressure[J]. Hypertension, 2006,47(5): 846-853.
7Di Bello V,Talarico L,Picano E,et al. Increased echodensity of myocardial wall in the diabetic hearts: an utrasound tissue characterization study[J]. JACC, 1995,25(6) : 1408-1415.
8Di Bello V, Pedrinelli R, Giorgi D,et al. Ultrasonic myocardial texture versus Doppler analysis in hypertensive heart: a preliminary study[J]. Hypertension, 1999,33 ( 1 ) : 66-73.
9Verdecchia P, Schillaci G, Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension[J]. Circulation, 1990,81(2) : 528-536.
1[1]Lopez B,Gonzalez A,Querejeta R,et al.The use of collagenderived serum peptides for the clinical assessment of hypertensive heart disease[J].J Hypertens,2005,23:1445-1451.
2[2]Brilla CG,Janicki JS,Weber KT,et al.Impaired diastolic function and coronary in genetic hypertension.Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries[J].Circ Res,1991,69:107-115.
3[3]Kozàkovà M,Buralli S,Palombo C,et al.Myocardial ultrasonic backscatter in hypertension relation to aldosterone and endothelin[J].Hypertens,2003,41:230-236.
4[5]di Bello V,Talarico L,Picano E,et al.Increased echodensity of myocardial wall in the diabetic hearts:an ultrasound tissue characterization study[J].JACC,1995,25:1408-1415.
5[6]Di Bello V,Pedrinelli R,Giorgi D,et al.Ultrasonic myocardial texture versus Doppler analysis in hypertensive heart:a preliminary study[J].Hypertens,1999,33:66-73.
6[7]Sato A,Hayashi M,Saruta T.Relative long-term effects of spironolactone in conjunction with an angiotensin-converting enzyme inhibitor of left ventricular mass and diastolic function in patients with essential hypertension[J].Hypertens Res,2002,25:837-842.
8[9]Sasaguri M,Noda K,Tashiro E,et al.The regression of left ventricular hypertrophy by imidapril and the reduction of serum procollagen type Ⅲ amino-terminal peptide in hypertensive patients[J].Hypertens Res,2000,23:317-322.
9[10]Lin YH,Shiau YC,Yen RF,et al.The relation between myocardial cyclic variation of integrated backscatter and serum concentrations of procollagen propeptides in hypertensive patients[J].Ultrasound Med Biol,2004,30:885-891.
4Devereux RB, Reichheck N. Echocardiographic determination of left ventricular mass in man:anatomic validation of method [J]. Circulation, 1977,55(4):613-618.
5White WB. Expanding the use of ambulatory blood pressure monitoring for the diagnosis and management of patients with hypertension [J]. Hypertension,2006,47(1):14 -15.
6Yan GX, Rials SJ, Wu Y, et al. Ventricular hypertrophy amplifies transmural repolarization dispersion and induces early after depolarization[J]. Am J Physiol Heart Circ Physiol, 2001,281(5) :H1968-1975.
7Mayet J, Shahi M. Left ventricular hypertrophy and QT dis perslon in hypertension[J]. Hypertension, 1996,28 (5):791- 796.
8Manfredini R, Boari B, Portaluppi F. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives [J]. Circulation, 2003, 108 (10):72- 73.
9Kaneda R,Kario K, Hoshide S, et al. Morning blood pressure hyper reactivity is an independent predictor for hypertensive cardiac hypertrophy in a community-dwelling poulation[J]. Am Hypertens,2005,18(12 Pt 1) :1528-1533.
